**Core Concept**
Unconjugated hyperbilirubinemia occurs when there is an excessive production or decreased uptake of unconjugated bilirubin. Kernicterus is a serious complication of untreated or severe jaundice, particularly in newborns. The risk of kernicterus is influenced by the levels of unconjugated bilirubin and its binding to albumin.

**Why the Correct Answer is Right**
The correct answer involves the mechanism of bilirubin binding to albumin. Unconjugated bilirubin is transported bound to albumin in the bloodstream. If the levels of unconjugated bilirubin exceed the binding capacity of albumin, it can cause a decrease in the binding of bilirubin to albumin. This leads to an increase in the levels of free unconjugated bilirubin, which can cross the blood-brain barrier and cause kernicterus. **Phenobarbital** increases the conjugation of bilirubin, thereby reducing the levels of unconjugated bilirubin. However, **Sulfisoxazole** reduces the binding of bilirubin to albumin, thereby increasing the risk of kernicterus.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is not relevant to the question. The other options involve specific medications that can affect bilirubin levels.
* **Option B:** This option is incorrect because it does not directly relate to the risk of kernicterus in unconjugated hyperbilirubinemia. The correct answer involves a medication that affects bilirubin binding to albumin.
* **Option D:** This option is incorrect because it does not directly relate to the risk of kernicterus in unconjugated hyperbilirubinemia. The correct answer involves a medication that affects bilirubin binding to albumin.

**Clinical Pearl / High-Yield Fact**
It is essential to remember that medications that reduce bilirubin binding to albumin can increase the risk of kernicterus in unconjugated hyperbilirubinemia. This is particularly relevant in newborns, where kernicterus can cause serious complications.

**Correct Answer:** C. Sulfisoxazole.